^(18)F-FDG PET/CT在胸腺上皮肿瘤中的临床应用现状与研究进展  

Status and Research Progress in the Clinical Use of 18FFDG PET/CT for Thymic Epithelial Tumors

作　　者：杜叶宁 邵科龙 叶雪梅[2] 毛伟敏[2,3] DU Yening;SHAO Kelong;YE Xuemei;MAO Weimin(The Second School of Clinical Medicine,Zhejiang Chinese Medical University,Hangzhou 310053,China;Zhejiang Cancer Hospital,Hangzhou Institute of Medicine(HIM),Chinese Academy of Sciences,Hangzhou 310022,China;Zhejiang Provincial Key Laboratory of Thoracic Cancer Diagnosis and Treatment Technology Research,Hangzhou 310022,China)

机构地区：[1]浙江中医药大学第二临床医学院,浙江杭州310053 [2]浙江省肿瘤医院,中国科学院杭州医学研究所,浙江杭州310022 [3]浙江省胸部肿瘤诊治技术研究重点实验室,浙江杭州310022

出　　处：《中国肿瘤》2024年第9期781-787,共7页China Cancer

基　　金：江西省重点研发计划项目(20212BBG71006)。

摘　　要：在临床实践中,传统的影像学检查手段对于胸腺上皮肿瘤(thymic epithelial tumors,TETs)的诊断价值有限。^(18)F-FDG PET/CT作为一种非侵入性成像方式,已被证实在其他实体肿瘤诊断中发挥了重要作用。随着^(18)F-FDG PET/CT的普及,其在TETs的应用价值也逐步凸显。全文总结了^(18)F-FDG PET/CT在TETs诊断、分期、监测治疗反应和预后等方面的应用现状与研究进展,以期为TETs的临床诊疗提供参考。In clinical practice,conventional imaging modalities have limited diagnostic value for thymic epithelial tumors(TETs).However,^(18)F-FDG PET/CT,as a non-invasive imaging modality,has been shown to play a significant role in other solid tumors.With the increasing use of^(18)F-FDG PET/CT,its application value in thymic epithelial tumors has been increasingly emphasized.This paper summarizes the current status and research progress of the application of^(18)F-FDG PET/CT in diagnosing,staging,monitoring treatment responses,and predicting outcomes for TETs,in order to offer assistance for clinical diagnosis and treatment of thymic epithelial tumors.

关 键 词：胸腺上皮肿瘤 正电子发射断层扫描 氟代脱氧葡萄糖 组织病理学 

分 类 号：R736.3[医药卫生—肿瘤]